Long-term effectiveness of Pfizer/BioNTech two-dose regimen mRNA vaccine – News-Medical.Net

Several studies have shown the effectiveness of the BioNTech/Pfizer messenger ribonucleic acid (mRNA) BNT162b2 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine. Two doses of the vaccine have been shown to provide a short-term effect.
…

Click here to view the original article.